NC
TECH icon

NewSquare Capital’s Bio-Techne TECH Stock Holding History

NewSquare Capital’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-300
Closed -$15.4K – 1121
2025
Q2 		$15.4K Buy
300
+260
+650% +$13.1K ﹤0.01% 539
2025
Q1 		$2.35K Buy
40
+36
+900% +$2.44K ﹤0.01% 826
2024
Q4 		$288 Buy
+4
New +$294 ﹤0.01% 827

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

NewSquare Capital's TECH Position: Q3 2025 in Review

NewSquare Capital sold out of Bio-Techne (TECH) in Q3 2025, closing a stake of 300 shares — an estimated $15.4K sold.

NewSquare Capital first reported a position in TECH in Q4 2024 and held it in 3 quarters. The position peaked at $15.4K in Q2 2025. 577 funds tracked by Wall St. Rank hold TECH as of Q3 2025.

  • NewSquare Capital reported no remaining Bio-Techne position as of Q3 2025 after selling out during the quarter.
  • NewSquare Capital sold 300 Bio-Techne shares in Q3 2025, an estimated $15.4K.
  • NewSquare Capital first reported a position in Bio-Techne in Q4 2024 and held it in 3 quarters.
  • NewSquare Capital's Bio-Techne position peaked at $15.4K in Q2 2025.
  • 577 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2025.

Based on NewSquare Capital's 13F filing for Q3 2025, filed 12 Nov 2025.